I was thinking the same thing, I was thinking that Elite bought these drugs in case Lisdex wasn’t approved, but once the approval came in, it was full steam ahead in the production of Lisdex and any new additions would have to wait there turn. When Carter had mentioned January shipment and February being similar, it seems to me everything was falling in place. The new facility didn’t get approved until 2025, so next quarter earning should be good or better than expected. I wouldn’t listen to a person that needs to use his credit card to buy stocks, would you?
Market Data 
Markets 
AI
